| Teva Pharmaceutical Industries Limited (TEVA) | |||
|---|---|---|---|
| 10.2 -0.42 (-3.95%) | 01-17 16:02 | ||
| Open: | 10.67 | Pre. Close: | 10.62 |
| High: | 10.68 | Low: | 10.15 |
| Volume: | 15,848,180 | Market Cap: | 11218M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 10.709 - 10.763 | 10.763 - 10.797 |
| Low: | 10.024 - 10.094 | 10.094 - 10.139 |
| Close: | 10.1 - 10.205 | 10.205 - 10.272 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 13.00 One year: 15.18 |
| Support: | Support1: 9.67 Support2: 8.77 |
| Resistance: | Resistance1: 11.13 Resistance2: 13.00 |
| Pivot: | 9.59  |
| Moving Averages: | MA(5): 10.11 MA(20): 9.70 MA(100): 8.61 MA(250): 11.04 |
| MACD: | MACD(12,26): 0.10 Signal(12,26,9): -0.01 |
| %K %D: | %K(14,3): 74.97 %D(3): 74.28 |
| RSI: | RSI(14): 57.92 |
| 52-Week: | High: 20.21 Low: 6.07 Change(%): -45.6 |
| Average Vol(K): | 3-Month: 1800369 10-Days: 1661296 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.TEVA has closed below upper band by 22.9%. Bollinger Bands are 33.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Stock News |
|---|
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Specialty Generic | |
| Shares Out. (M) | 1090.00 |
| Shares Float (M) | 1040.00 |
| % Held by Insiders | 0.48 |
| % Held by Institutions | 54.76 |
| Shares Short (K) | 70330 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | -3.770 |
| Book Value (p.s.) | 12.630 |
| PEG Ratio | -0.99 |
| Profit Margin | -22.88 |
| Operating Margin | 15.30 |
| Return on Assets (ttm) | 2.7 |
| Return on Equity (ttm) | -25.4 |
| Qtrly Rev. Growth | -5.9 |
| Gross Profit (p.s.) | 7.615 |
| Sales Per Share | |
| EBITDA (p.s.) | 4.000 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 577.00 |
| Levered Free Cash Flow (M) | 1720.00 |
| Stock Valuation | |
|---|---|
| P/E | -2.71 |
| P/E Growth Ratio | -0.04 |
| P/BV | 0.81 |
| P/S | 0.62 |
| P/CF | 19.27 |
| Dividend Yield | |
| Dividends & Splits | |
|---|---|
| Dividend | |
| Dividend Pay Date | 2017-12-12 |
| Ex-Dividend Date | 2017-11-27 |
| Forward Dividend | |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
